The US Direct-to-Consumer (DTC) Laboratory Testing market is witnessing rapid growth, driven by advancements in digital health and increasing consumer awareness. This sector provides consumers with easy access to lab testing without physician orders, ensuring privacy and convenience. The market is anticipated to grow at a robust CAGR of 12.1% from 2024 to 2035, with the market size valued at USD 2,160 Million in 2025 and projected to reach USD 7,350 Million by 2035.
The economic impact of tariffs on "US Direct-to-Consumer Laboratory Testing".
Market Growth Drivers
Rising Consumer Awareness & Health Monitoring: Growing consumer focus on proactive health management is significantly boosting the US DTC laboratory testing market. With increased prevalence of chronic and lifestyle-related diseases such as diabetes and heart conditions, individuals are seeking affordable and convenient options to monitor their health periodically. Companies like LetsGetChecked have capitalized on this trend by offering user-friendly home sample collection kits and accessible online result platforms, enabling customers to manage their health without intermediary healthcare providers.
Expansion of Digital Health Platforms: The integration of digital health solutions is another key driver for the US DTC laboratory testing market. Advanced mobile applications, telemedicine integration, and AI-driven result interpretation have streamlined the testing process and made it more consumer-centric. For example, Everlywell provides comprehensive at-home testing services with secure digital result delivery, expert virtual consultations, and tailored health insights, driving greater adoption among tech-savvy consumers and expanding the potential user base.
Market Trends
Personalized Wellness and Preventive Testing: There is a noticeable shift towards personalized health testing, with customers seeking tests tailored to their genetic profile, lifestyle, or preventive health goals. Companies like 23andMe are expanding their services to encompass not just ancestry but also health risk assessments based on genetic markers. This trend is fostering innovation in custom health panels, integrating advanced analytics to interpret complex results for end-users.
Expansion of At-Home Sample Collection Technology: Recent advancements in sample collection technology, including dried blood spot and saliva-based testing, are making it easier and safer for consumers to collect samples at home. Labcorp OnDemand, for instance, has introduced more reliable and minimally invasive collection kits, improving user compliance and enabling growth in remote diagnostic services. These innovations are setting new industry standards in convenience and accuracy.
Market Opportunity
Integration with Insurance and Employer Health Plans: There is growing opportunity for DTC labs to partner with insurance providers and large employers to offer health screenings as part of wellness programs. Companies such as QuestDirect are strategically forming alliances with payers to boost consumer access and affordability.
Expansion into Specialized Testing Segments: DTC labs can gain market share by developing niche offerings such as fertility, hormonal, and mental health tests. Everly Health is targeting these specialized areas, leveraging telehealth support for interpretation and next steps, appealing to underserved markets.
US Direct-to-Consumer Laboratory Testing Market Revenue (USD Million), 2020-2035
The revenue chart illustrates the accelerating momentum of the US DTC laboratory testing market from 2020 to 2035. Beginning with a market size of USD 800 Million in 2020, the sector expands steadily, driven by rising consumer adoption and technological innovation. By 2025, the market is forecasted to reach USD 2,160 Million, with exponential growth projected onwards as digital health becomes mainstream. The CAGR of 12.1% reflects increasing acceptance and integration of DTC testing in routine healthcare. By 2035, industry revenues are expected to surpass USD 7,350 Million, marking a strong upward trajectory and signaling significant investment opportunities in this space.
US Direct-to-Consumer Laboratory Testing Market by Region Share (%), 2025
The 2025 market share by region highlights notable geographic variations in DTC testing adoption across the US. The South leads with 34%, driven by large populations and rising health awareness campaigns. The West follows with 25%, buoyed by tech-savvy consumers and early adopter culture in states like California. The Midwest holds 18% share, thanks to partnerships with regional health systems, while the Northeast accounts for 20% due to dense urban populations and robust digital infrastructure. Other regions, including Alaska and Hawaii, contribute 3%, representing nascent but growing markets aided by telehealth advances.
Recent Developments in US Direct-to-Consumer Laboratory Testing (Past 6 Months)
Everlywell announced the launch of its new advanced women’s health panel in April 2024, expanding its suite of hormone and wellness tests. The new offering includes personalized recommendations and telehealth support for test result interpretation. This significant move responds to increasing demands for specialized and accessible testing options for women, positioning Everlywell as a leader in women's digital health management.
Labcorp OnDemand formed a strategic partnership with CVS Health in May 2024, enabling customers to order select DTC tests directly through CVS’s digital platform and access sample collection at participating retail locations. This collaboration is expected to expand consumer access and streamline logistics, offering a seamless integration of digital lab testing and traditional pharmacy infrastructure.
In March 2024, QuestDirect integrated AI-powered risk assessment tools into its online testing platform, providing instant, customized recommendations based on users’ results and risk factors. This integration enhances user experience by making result interpretation more actionable and has the potential to improve early intervention and health outcomes by leveraging predictive healthcare analytics.
Press Releases